Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey

Harm Reduction Journal

Ivana Bozicevic³  Itana Labovic²  Zoran Vratnica¹  Natasa Terzic¹  Boban Mugosa¹  Senad Begic¹  Dragan Lausevic¹ 

[1] Institute for Public Health, Podgorica, Montenegro;HIV/AIDS Office, United Nations Development Programme, Podgorica, Montenegro;World Health Organization Collaborating Centre for HIV Surveillance, School of Medicine, University of Zagreb, Zagreb, Croatia

关键词: Montenegro;    Survey;    Hepatitis C;    HIV;    People who inject drugs;   

Others  :  1207719
DOI  :  10.1186/s12954-015-0039-0

 received in 2014-11-11, accepted in 2015-02-04,  发布年份 2015

【 摘 要 】

Background

People who inject drugs (PWID) have significantly higher rates of blood borne and sexually transmitted infections due to unsafe injecting practices and risky sexual behaviors.

Methods

We carried out an HIV bio-behavioral survey using respondent-driven sampling (RDS) in people who use drugs (PWID) in Podgorica, Montenegro in 2013 in order to determine the prevalence of HIV, hepatitis C (HCV), hepatitis B surface antigen (HBsAg) and risk behaviors. Data were analyzed using RDS Analyst and SPSS 12.0 to obtain prevalence estimates of key bio-behavioral indicators and assess correlates of needle and syringe sharing using multivariate logistic regression.

Results

A total of 402 PWID were recruited. HIV prevalence was 1.1%, while the prevalence of HCV and HBsAg was 53.0% and 1.4%, respectively. In the multivariate analysis, significant correlates of needle and syringe sharing in the past month were being older than 26 years, female, injecting drugs more than once per day, injecting in parks or on streets, not being able to obtaining free-of-charge sterile needles and syringes and reporting more than four partners in the past 12 months.

Conclusions

The results indicate that the HIV epidemic in PWID in Montenegro might still be at a low level, though the HCV epidemic is well-established.

【 授权许可】

   
2015 Lausevic et al.; licensee BioMed Central.

【 参考文献 】

• [1]Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA et al.. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2007; 2008(372):1733-45.
• [2]Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Semaan S. Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health. 2011; 101:1277-83.
• [3]Statistical Yearbook 2011. Podgorica: Statistical Office of the Republic of Montenegro; 2012.
• [4]Annual Report on HIV/AIDS in Montenegro. Podgorica: Institute for Public Health; 2014.
• [5]HIV/AIDS Strategy for the Republic of Montenegro 2005–2009. Podgorica: Government of the Republic of Montenegro; 2005
• [6]Lausevic D, Mugosa B, Vratnica Z, Terzic N, Strahinja R, Labovic I. Survey on HIV Risk Behaviours and Prevalence of HIV, HBV and HCV Among Injecting Drug Users in Montenegro in 2008. Institute for Public Health, Podgorica; 2008.
• [7]Lausevic D, Mugosa B, Vratnica Z. Survey on HIV Risk Behaviours and HIV, HBV and HCV Prevalence Among Injecting Drug Users in Montenegro in 2011. Institute for Public Health, Podgorica; 2011.
• [8]Heckathorn D. Respondent driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997; 44:174-99.
• [9]Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005; 19(suppl 2):S67-72.
• [10]Behavioural surveillance surveys: guidelines for repeated behavioural surveys in populations at risk of HIV. Arlington: Family Health International, 2000. Available at: http://www.who.int/hiv/strategic/en/bss_fhi2000.pdf Accessed on 29 January 2015.
• [11]Handcock MS, Fellows IE, Gile KJ. RDS Analyst: software for the analysis of respondent-driven sampling data, Version 0.42. Available at: http://hpmrg.org. Accessed on 22 September 2014.
• [12]Judd A, Rhodes T, Johnston LG, Platt L, Andjelkovic V, Simić D, et al. Improving survey method in sero-epidemiological studies of injecting drug users : a case example of two cross-sectional surveys in Serbia and Montenegro. BMC Infect Dis. 2009; 9–14. doi: 10.1186/1471-2334-9-14.
• [13]Bacak V, Dominkovic Z. Behavioral and Biological Surveillance Study Among Injection Drug Users in Bosnia and Herzegovina: A Respondent-Driven Sampling Survey. Public Health Institute, Banja Luka; 2012.
• [14]Vilibic-Cavlek T, Maric J, Katicic L, Kolaric B. Hepatitis C virus antibody status, sociodemographic characteristics and risk behavior among injecting drug users in Croatia. Cent Eur J Public Health. 2011; 19:26-9.
• [15]Mikik V, Kuzmanovska G, Memeti S. Report from the Bio-Behavioural Survey Among Injecting Drug Users and Assessment Of Population Size of Injecting Drug Users in Macedonia, 2010. Institute for Public Health of the Republic of Macedonia, Skopje; 2011.
• [16]Preventing HIV Infection Among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence. Institute of Medicine of the US National Academies, Washington DC; 2006.
• [17]Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008; 2: Article ID CD004145
• [18]HIV/AIDS prevention and care for female injecting drug users. Vienna: United Nations Office on Drugs and Crime; 2006.
• [19]Benotsch EG, Somlai AM, Pinkerton SD, Kelly JA, Ostrovski D, Gore-Felton C et al.. Drug use and sexual risk behaviours among female Russian IDUs who exchange sex for money or drugs. Int J STD AIDS. 2004; 15:343-7.
• [20]Cleland CM, Des Jarlais DC, Perlis TE, Stimson G, Poznyak V. HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health. 2007; 7:271. BioMed Central Full Text
• [21]Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012; 124:95-107.
• [22]Assari S, Yarmohmmadi Vasel M, Tavakoli M, Sehat M, Jafari F, Narenjiha H, et al. Inconsistent condom use among Iranian male injection drug users. Front Psychiatry 2014, 181. doi: 10.3389/fpsyt.2013.00181. eCollection 2013.
• [23]Schumacher CM, Go VF, le Nam V, Latkin CA, Bergenstrom A, Celentano DD et al.. Social injecting and other correlates of high-risk sexual activity among injecting drug users in northern Vietnam. Int J Drug Policy. 2009; 20:352-6.
• [24]Chikovani I, Bozicevic I, Goguadze K, Rukhadze N, Gotsadze G. Unsafe injection and sexual risk behavior among injecting drug users in Georgia. J Urban Health. 2011; 88:736-48.
• [25]Neaigus A, Reilly KH, Jenness SM, Hagan H, Wendel T, Gelpi-Acosta C. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City. AIDS Behav. 2013; 17:2501-9.
• [26]Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997; 92:1457-65.
• [27]Miller CL, Strathdee SA, Li K, Kerr T, Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users. Am J Drug Alcohol Abuse. 2007; 33:527-36.
• [28]Degenhardt L, Kinner SA, Roxburgh A, Black E, Bruno R, Fetherston J et al.. Drug use and risk among regular injecting drug users in Australia: does age make a difference? Drug Alcohol Rev. 2008; 27:357-60.
• [29]Paquete D, Bryant J, de Wit J. Respondent driven sampling and the recruitment of people with small injecting networks. AIDS Behav. 2012; 16:890-9.